JPH03502931A - 新規o‐(3‐アミノ‐2‐ヒドロキシプロピル)‐ヒドロキサム酸ハロゲン化物およびその製造方法 - Google Patents
新規o‐(3‐アミノ‐2‐ヒドロキシプロピル)‐ヒドロキサム酸ハロゲン化物およびその製造方法Info
- Publication number
- JPH03502931A JPH03502931A JP1510821A JP51082189A JPH03502931A JP H03502931 A JPH03502931 A JP H03502931A JP 1510821 A JP1510821 A JP 1510821A JP 51082189 A JP51082189 A JP 51082189A JP H03502931 A JPH03502931 A JP H03502931A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- general formula
- tables
- formulas
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/08—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Description
Claims (8)
- 1.式(I) ▲数式、化学式、表等があります▼(I)[式中 Xはフロオロ、クロロ、ブロモおよびヨードのようなハロゲンであり、 R1は水素またはC1〜5アルキルであり、R2はC1〜5アルキル、C5〜7 シクロアルキルまたはフェニル(それぞれは場合によりヒドロキシによつて置換 されている)であり、かつ R2およびR3は隣接窒素原子と一緒になつて場合により付加的な窒素原子およ び/または酸素原子を含有する5〜8員環を形成し、該環はベンゼン環と縮合し ていてもよく、R3は水素、場合により1つまたは幾つかのハロゲンまたはアル コキシで置換されているフエニル、ナフチルまたはピリジルであり、R4は水素 またはフエニルであり、 R5は水素またはフエニルてあり、 mは0,1または2の整数であり、 nは0,1または2の整数である〕で示されるヒドロキサム酸誘導体およびその 塩。
- 2.請求項1に記載された式(I)で示されるヒドロキサム酸誘導体およびその 塩の製造方法において、a)一般式(III): ▲数式、化学式、表等があります▼(III)〔式中、R3,R4,R5,mお よびnは請求項1に記載ししたものてある〕で示されるアルドオキシムを、塩基 の存在で、式(IV/A): ▲数式、化学式、表等があります▼(IVA)および(IV/B):) ▲数式、化学式、表等があります▼(IVB)〔上記式中R1およびR2は請求 項1に記載したものであり、Xはハロゲンである〕で示されるアミンと反応させ るか、または b)一般式(III)〔式中R1,R2,R3,mおよびnは請求項1に記載し たものである〕で示されるアルドオキシムをエピクロロヒドリンと反応させ、こ うして得られた一般式(VI): ▲数式、化学式、表等があります▼(IV)で示されるアルドオキシム誘導体を 一般式(V))▲数式、化学式、表等があります▼(V)〔式中R1およびR2 は上記のものを表わす〕で示されるアミンと反応させ、方法a)またはb)のい ずれかにより得られる式(VII): ▲数式、化学式、表等があります▼(VII)〔式中R3,R4,R5,mおよ びnは上記のものである〕て示されるアルドオキシム誘導体を、単離後または単 離せずに、無機の酸ハロゲン化物または他のハロゲン化剤と反応させ、こうして 得られる一般式(VIII):▲数式、化学式、表等があります▼(VIII) で示されるヒドロキサム酸ハロゲン化物を、直接かまたはエステル誘導体を経て 、水・アルカリ性媒体中で加水分解するか、または c)一般式(II): ▲数式、化学式、表等があります▼(II)〔式中置換基は上記のものである〕 で示されるアルドオキシム誘導体をNaNO2およびHX(ただしXはハロゲン である)の存在でジアゾ化し、こうして得られるジアゾニウム塩を、単離せずに または単離後、“煮沸”反応にかけ、必要に応じて反応の間に得られた遊離塩基 を、有機酸または無機酸と反応させて酸付加塩に変えるか、またはその塩の形で 得られた化合物から遊離塩基を生成することを特徴とする請求項1記載のヒドロ キサム酸誘導体およびその塩の製造方法。
- 3.反応を溶媒中で実施する、請求項2記載の方法。
- 4.溶媒として水、水と有機溶媒の混合物、または水相と有機溶媒相を含有する 混合物を使用する、請求項3記載の方法。
- 5.反応を−10〜+140℃の温度で実施する、請求項2から4までのいずれ か1項記載の方法。
- 6.一般式(VII)〔式中R1,R2,R3,R4,R5,X,mおよびnは 請求項1に記載したものである〕で示される化合物。
- 7.活性成分として一般式(1)で示される1種または数種の化合物を含有する ことを特徴とする、糖尿病の場合に特殊なβ遮断効果を有する医薬調剤。
- 8.糖尿病の治療における一般式(I)で示される化合物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU5405/88 | 1988-10-20 | ||
HU885405A HU207988B (en) | 1988-10-20 | 1988-10-20 | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
PCT/HU1989/000048 WO1990004584A1 (en) | 1988-10-20 | 1989-10-19 | Novel o-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03502931A true JPH03502931A (ja) | 1991-07-04 |
JPH0819078B2 JPH0819078B2 (ja) | 1996-02-28 |
Family
ID=10970243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1510821A Expired - Fee Related JPH0819078B2 (ja) | 1988-10-20 | 1989-10-19 | 新規o‐(3‐アミノ‐2‐ヒドロキシプロピル)‐ヒドロキサム酸ハロゲン化物およびその製造方法 |
Country Status (20)
Country | Link |
---|---|
US (3) | US5147879A (ja) |
EP (1) | EP0417210B1 (ja) |
JP (1) | JPH0819078B2 (ja) |
KR (1) | KR0154117B1 (ja) |
AU (1) | AU620460B2 (ja) |
CA (1) | CA2000830C (ja) |
DE (1) | DE68913737T2 (ja) |
DK (1) | DK175584B1 (ja) |
ES (1) | ES2020030A6 (ja) |
FI (1) | FI93214C (ja) |
GR (1) | GR1002253B (ja) |
HU (1) | HU207988B (ja) |
IE (1) | IE65113B1 (ja) |
IL (1) | IL92000A (ja) |
NO (1) | NO178148C (ja) |
PL (1) | PL164547B1 (ja) |
PT (1) | PT92041B (ja) |
RU (1) | RU2093508C1 (ja) |
UA (1) | UA34412C2 (ja) |
WO (1) | WO1990004584A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002537384A (ja) * | 1999-02-26 | 2002-11-05 | ビオレックス クタトー エス フェイレストェー アールテー. | N−[2−ヒドロキシ−3−(1−ピペリジニル)プロポキシ]ピリジン−1−オキシド−3−カルボキシイミドイルクロライド及びそのインスリン抵抗性の治療における使用 |
JP2004537550A (ja) * | 2001-07-17 | 2004-12-16 | エヌ−ジーン リサーチ ラボラトリーズ インク | 糖尿病予防、または糖尿病治療のための相乗作用を持つ薬学的組み合わせ |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9507619A (pt) * | 1994-05-06 | 1997-09-23 | Biorex Kutato Fejlesztoe Kft | Novos derivados de ácido hidroxímico composições farmacêuticas contendo os mesmos e processo para preparação dos mesmos |
US5665756A (en) * | 1994-08-03 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
HU9502843D0 (en) * | 1995-09-29 | 1995-11-28 | Livigene Ltd | Pharmaceutical composition |
HU222994B1 (hu) | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
US6458371B1 (en) | 1995-12-22 | 2002-10-01 | Medgene, Limited | Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin |
HUT78138A (hu) | 1995-12-22 | 2000-09-28 | BIOREX Kutató és Fejlesztő Rt | Hidroximsavszármazékot tartalmazó készítmény a növénytermesztés elősegítésére és alkalmazása |
HUT78139A (hu) * | 1995-12-22 | 2000-11-28 | BIOREX Kutató és Fejlesztő Rt. | Készítmény, különösen a bőr öregedési folyamatainak mérséklésére |
AU745987B2 (en) * | 1995-12-22 | 2002-04-11 | N-Gene Research Laboratories Inc. | A cosmetic composition and a method for reducing the ageing processes of skin |
US6884424B2 (en) | 1995-12-22 | 2005-04-26 | N-Gene Research Laboratories Inc. | Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight |
DE19607960A1 (de) * | 1996-03-01 | 1997-09-04 | Hoechst Schering Agrevo Gmbh | Verfahren zur Herstellung von Ketonoximether durch Boronsäurekupplung |
GB9613339D0 (en) * | 1996-06-26 | 1996-08-28 | Kritzinger Ann C | Limp bookbinding assembly technique for two books in one pass |
UA64716C2 (en) * | 1996-08-09 | 2004-03-15 | Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells | |
HU220971B1 (hu) * | 1997-04-03 | 2002-07-29 | BIOREX Kutató és Fejlesztő Rt. | Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására |
HU9701081D0 (en) | 1997-06-23 | 1997-08-28 | Gene Research Lab Inc N | Pharmaceutical composition of antitumoral activity |
AU5296799A (en) * | 1998-08-03 | 2000-02-28 | N-Gene Kutato Kft. | Pharmaceutical compositions against autoimmune diseases |
US6933104B1 (en) | 1999-04-23 | 2005-08-23 | Shiva Biomedical, Llc | Diagnosis and treatment of human kidney diseases |
HUP0001583A2 (hu) * | 2000-04-18 | 2002-11-28 | BIOREX Kutató és Fejlesztő Rt. | Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké |
HUP0105205A2 (hu) * | 2001-11-29 | 2003-08-28 | BIOREX Kutató és Fejlesztő Rt. | Metformint és egy hidroxilaminszármazékot tartalmazó, gyógyászati készítmény |
AU2002367171B2 (en) * | 2001-12-21 | 2008-02-21 | Rhodia Inc. | Combined stable cationic and anionic surfactant compositions |
AU2003202104B8 (en) * | 2002-01-11 | 2008-10-02 | Cytrx Corporation | Carboxamidine derivatives and their use in the treatment of vascular diseases |
HUP0303584A3 (en) | 2003-10-30 | 2009-12-28 | Cytrx Corp | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
DE10351448A1 (de) * | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
US20080227813A1 (en) * | 2006-09-26 | 2008-09-18 | Jack Raymond Barber | Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration |
US7763601B2 (en) * | 2006-11-02 | 2010-07-27 | N-Gene Research Laboratories, Inc. | Prevention and treatment of obesity |
EP2356988A4 (en) | 2008-11-18 | 2012-05-09 | Santen Pharmaceutical Co Ltd | THERAPEUTIC FOR CHORIORETINAL DEGENERATION WITH PYRIDINE-3-CARBALDEHYDE O- (PIPERIDIN-1-YL-PROPYL) OXIM DERIVATIVE AS ACTIVE SUBSTANCE |
HUP1100534A2 (en) | 2011-09-26 | 2013-04-29 | Balazs Dr Hazay | Pharmaceutical composition for the treatment of muscle atrophy |
HUP1100535A2 (en) | 2011-09-26 | 2013-04-29 | Bracelia Invest Ltd | Pharmaceutical composition for enhancement of stem cell treatment |
KR101995300B1 (ko) | 2018-03-30 | 2019-10-17 | 주식회사 아세아텍 | 다목적 관리기용 작업기 탈부착장치 |
HUP1800298A1 (hu) | 2018-08-30 | 2020-05-28 | N Gene Res Laboratories Inc | Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére |
CN112174853B (zh) * | 2020-11-03 | 2023-07-25 | 湖南经世新材料有限责任公司 | 一种氨解法制备(z)-n-羟基苯脒的方法 |
EP4247792A1 (en) | 2020-11-19 | 2023-09-27 | Zevra Denmark A/S | Processes for preparing arimoclomol citrate and intermediates thereof |
WO2023053008A1 (en) * | 2021-09-28 | 2023-04-06 | Kempharm Denmark A/S | Oximes and their use in treatment of gba-related diseases |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670497C3 (de) * | 1967-06-06 | 1973-12-20 | Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest | Isochinohnderivate und Verfahren zu deren Herstellung |
HU177578B (en) * | 1976-08-27 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives |
US4187220A (en) * | 1977-08-30 | 1980-02-05 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
US4308399A (en) * | 1977-08-30 | 1981-12-29 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. | O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
EP0369944A1 (de) * | 1988-11-18 | 1990-05-23 | Ciba-Geigy Ag | Substituierte Oxadiaminobutane |
FR2639942B1 (fr) * | 1988-12-02 | 1991-03-29 | Sanofi Sa | Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant |
HUT54347A (en) * | 1989-01-10 | 1991-02-28 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoximes |
-
1988
- 1988-10-20 HU HU885405A patent/HU207988B/hu unknown
-
1989
- 1989-10-16 IL IL9200089A patent/IL92000A/en not_active IP Right Cessation
- 1989-10-17 CA CA002000830A patent/CA2000830C/en not_active Expired - Lifetime
- 1989-10-19 GR GR890100669A patent/GR1002253B/el not_active IP Right Cessation
- 1989-10-19 DE DE68913737T patent/DE68913737T2/de not_active Expired - Lifetime
- 1989-10-19 UA UA4830570A patent/UA34412C2/uk unknown
- 1989-10-19 WO PCT/HU1989/000048 patent/WO1990004584A1/en active IP Right Grant
- 1989-10-19 IE IE336489A patent/IE65113B1/en not_active IP Right Cessation
- 1989-10-19 RU SU894830570A patent/RU2093508C1/ru active
- 1989-10-19 US US07/499,318 patent/US5147879A/en not_active Expired - Lifetime
- 1989-10-19 PT PT92041A patent/PT92041B/pt not_active IP Right Cessation
- 1989-10-19 JP JP1510821A patent/JPH0819078B2/ja not_active Expired - Fee Related
- 1989-10-19 EP EP89911590A patent/EP0417210B1/en not_active Expired - Lifetime
- 1989-10-19 KR KR1019900701346A patent/KR0154117B1/ko not_active IP Right Cessation
- 1989-10-19 PL PL89281898A patent/PL164547B1/pl unknown
- 1989-10-19 AU AU44186/89A patent/AU620460B2/en not_active Expired
- 1989-10-20 ES ES8903542A patent/ES2020030A6/es not_active Expired - Fee Related
-
1990
- 1990-06-18 NO NO902703A patent/NO178148C/no unknown
- 1990-06-19 FI FI903075A patent/FI93214C/fi active IP Right Grant
- 1990-06-19 DK DK199001497A patent/DK175584B1/da not_active IP Right Cessation
-
1992
- 1992-07-01 US US07/906,402 patent/US5296606A/en not_active Expired - Lifetime
-
1993
- 1993-06-07 US US08/072,765 patent/US5328906A/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002537384A (ja) * | 1999-02-26 | 2002-11-05 | ビオレックス クタトー エス フェイレストェー アールテー. | N−[2−ヒドロキシ−3−(1−ピペリジニル)プロポキシ]ピリジン−1−オキシド−3−カルボキシイミドイルクロライド及びそのインスリン抵抗性の治療における使用 |
JP4689838B2 (ja) * | 1999-02-26 | 2011-05-25 | シトルックス コーポレイション | N−[2−ヒドロキシ−3−(1−ピペリジニル)プロポキシ]ピリジン−1−オキシド−3−カルボキシイミドイルクロライド及びそのインスリン抵抗性の治療における使用 |
JP2004537550A (ja) * | 2001-07-17 | 2004-12-16 | エヌ−ジーン リサーチ ラボラトリーズ インク | 糖尿病予防、または糖尿病治療のための相乗作用を持つ薬学的組み合わせ |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH03502931A (ja) | 新規o‐(3‐アミノ‐2‐ヒドロキシプロピル)‐ヒドロキサム酸ハロゲン化物およびその製造方法 | |
US7750028B2 (en) | Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1, 2,3-triazole-4-carboxamide | |
CA2471743A1 (en) | Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds | |
CA1263652A (en) | Substituted benzylphthalazinone derivatives | |
CS195744B2 (en) | Method of producing new derivatives of imidazole | |
US4035367A (en) | Hydroxyalkyl-substituted-amino-quinolines | |
JPS61197577A (ja) | 1−置換−6−フルオロ−7−(ピロ−ル−1−イル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸誘導体およびその製造法 | |
US4273776A (en) | Antibacterial and antifungal derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones | |
US4282230A (en) | Imidazolylethoxy derivatives of quinoline-2- or 4-methanols, antimicrobial compositions containing them and method for treating bacterial or fungal infections with them | |
CA1155842A (en) | Compounds | |
TW462960B (en) | 4-fluoroalkyl-substituted benzoylguanidines process for their preparation, their use as a medicament of diagnostic, and medicament containing them | |
EP0198235A2 (en) | Imidazole derivatives having antimycotic and antibacterial activities, a process for the preparation thereof and pharmaceutical compositions containing them | |
JPS6044307B2 (ja) | 新規のo−アルキル化オキシムおよび医薬としてのその用途 | |
IE48442B1 (en) | Imidazolylethyl ether derivatives of pyrazolo(3,4-b)pyridine-5-methanols | |
JPS60501207A (ja) | 化合物 | |
JPH0466579A (ja) | チアゾリジン誘導体 | |
US4973691A (en) | Etheric derivative of 4(3H)-quinazolinone and a process for preparation thereof | |
US4317831A (en) | Antimicrobial derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones | |
JPS62158281A (ja) | 新規な3‐メチル‐フエニルナフチリジンおよびこれを含む医薬 | |
US4235910A (en) | Benzoquinolizines having blood pressure lowering activity, and in some instances, anti-secretory activity | |
JPS5846090A (ja) | フラノ−クロモン誘導体、それらの製造方法及びそれらを含有する薬用製剤 | |
US4207320A (en) | Amino-substituted imidazo[1,2-a:3,4-a']diquinolin-15-ium salts compositions and method of use | |
NZ201795A (en) | Anilino-1,2,3-triazole derivatives and pharmaceutical compositions | |
JPS61249970A (ja) | 新規な置換2−(n−アルキニル−n−フエニルアミノ)イミダゾリン誘導体 | |
US3960882A (en) | Chemical compounds for trichomoniasis and candidiosis treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090228 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090228 Year of fee payment: 13 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090228 Year of fee payment: 13 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |